MedPath

Use of Intravenous Acetaminophen in Pediatrics Undergoing Spinal Fusion Surgery

Phase 3
Completed
Conditions
Scoliosis; Adolescence
Interventions
Registration Number
NCT04959591
Lead Sponsor
Asan Medical Center
Brief Summary

The purpose of this study is to investigate whether perioperative intravenous acetaminophen administration reduces postoperative pain and opioid consumption in adolescents and pediatric patients undergoing spinal fusion surgery.

Detailed Description

Spinal fusion surgery to correct scoliosis causes severe postoperative pain in adolescents and pediatric patients. Thus, appropriate control of postoperative pain has a significant impact on postoperative recovery, patient satisfaction and reduction of hospital stay. Although pain control was achieved through only opioids, the importance of multimodal analgesia has recently been emphasized as opioid addiction and side effects increase.

Acetaminophen is recommended as a key factor in multimodal analgesia and previous studies performed in adult spine surgery showed that intravenous administration of acetaminophen reduced the postoperative pain and opioid consumption. In addition, acetaminophen is a drug widely recognized for safety in adolescents and pediatric patients and has a fast and predictable analgesic effect. Therefore, the purpose of this study is to investigate whether perioperative intravenous acetaminophen administration reduces postoperative pain and opioid consumption in adolescents and pediatric patients undergoing spinal fusion surgery. Thus the specific aim of this trial the investigators will determine is;

1. The decrease in postoperative analgesic requirement following IV acetaminophen

2. The decrease in intensity of postoperative pain following IV acetaminophen

3. The quality of recovery including self-reported recovery, physical and functional recovery and length of stay

4. The preemptive analgesic effect of IV acetaminophen

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • American Society of Anesthesiologists (ASA) physical status 1-3
  • patients undergoing spinal fusion surgery
Read More
Exclusion Criteria
  • patients who refuse to participate in this study
  • patients unable to communicate due to mental impairment or developmental delay
  • patients allergic to acetaminophen or its additives or who are contraindicated in acetaminophen administration for other reasons
  • patients with existing liver diseases or dysfunction (i.e. active hepatitis, clinically relevant chronic liver conditions, elevated liver enzymes)
  • patients who are judged ineligible by the medical staff to participate in the study for other reasons
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo comparator : placeboPlaceboParticipants will receive 1.5ml/kg placebo (0.9% saline) before and after surgery and the same dose will be given postoperatively at 8hour intervals for 24hours.
Experimental(post): Acetaminophenintravenous acetaminophenParticipants will receive 15mg/kg intravenous acetaminophen 15mg/kg at the end of surgery before skin closure and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given after anesthetic induction/before surgical incision.
Experimental (Pre): Acetaminophenintravenous acetaminophenParticipants will receive 15mg/kg intravenous acetaminophen 15mg/kg after anesthetic induction/before surgical incision and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given at the end of surgery before skin closure.
Primary Outcome Measures
NameTimeMethod
Postoperative analgesic consumption24 hours after surgery

Comparison of total analgesic consumption between 3 groups in morphine equivalent

Secondary Outcome Measures
NameTimeMethod
Frequency of side effects of opioids24, 48, 72 hours after surgery

respiratory depression, postoperative nausea/vomiting, itching, constipation

Post operative pain scores4, 8, 24, 48 hours after surgery

Comparison of NRS(numerical rating scale: 0, no pain, 10, worst possible pain) between 3 groups: Worst (cough) and mean pain scores

Postoperative recoveryfrom end of surgery to discharge from hospitalization (average 7 days)

Timing of oral intake(hr), timing of ambulation(hr)

Postoperative analgesic consumption48 hours after surgery

Comparison of total analgesic consumption between 3 groups in morphine equivalent

Length of hospital dayfrom end of surgery to discharge from hospitalization (average 7 days)

postoperative hospital stay(days), intensive care unit admission(days)

Quality of recovery questionaire3 to 5 days after surgery

self reported Quality of recovery-15 (QoR-15: 0, very poor recovery, 150, excellent recovery) questionnaire

Trial Locations

Locations (1)

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath